StockNews.com Begins Coverage on Senseonics (NYSE:SENS)

Analysts at StockNews.com started coverage on shares of Senseonics (NYSE:SENS) in a research report issued on Wednesday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $2.00 price objective on shares of Senseonics in a research note on Friday, November 15th.

Senseonics Stock Up 8.9 %

SENS stock opened at $0.44 on Wednesday. The firm has a fifty day moving average price of $0.34 and a two-hundred day moving average price of $0.38. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. Senseonics has a 1-year low of $0.25 and a 1-year high of $0.75. The firm has a market cap of $263.13 million, a price-to-earnings ratio of -3.40 and a beta of 0.77.

Insider Buying and Selling

In other Senseonics news, CFO Frederick T. Sullivan purchased 124,933 shares of the business’s stock in a transaction dated Thursday, December 12th. The shares were bought at an average price of $0.38 per share, with a total value of $47,474.54. Following the completion of the acquisition, the chief financial officer now owns 2,478,844 shares in the company, valued at approximately $941,960.72. This represents a 5.31 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Timothy T. Goodnow acquired 315,000 shares of Senseonics stock in a transaction dated Tuesday, December 10th. The shares were acquired at an average price of $0.31 per share, with a total value of $97,650.00. Following the completion of the transaction, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This trade represents a 2.86 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is owned by company insiders.

Institutional Trading of Senseonics

Several hedge funds have recently added to or reduced their stakes in the business. FMR LLC grew its stake in shares of Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after purchasing an additional 167,970 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in Senseonics in the third quarter worth about $117,000. Symmetry Partners LLC bought a new position in Senseonics in the 3rd quarter valued at about $164,000. Cubist Systematic Strategies LLC increased its stake in Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after buying an additional 85,501 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Senseonics by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock worth $2,042,000 after buying an additional 179,103 shares in the last quarter. Institutional investors own 12.36% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.